EUVIMEDObjevte EUVIMED
Crossref

Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

Daniel Alcalá Pérez, Ana Sofia Acosta Madiedo, Sebastian Andreani, Anneke Andriessen, Hebert Cárdenas, Marcela Moreno, Daniel Motola Kuba, Julia Riganti, José Enrique Ollague, Mario Lacouture, Alejandra Toquica

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.8565 ↗

At a glance

Journal article in Journal of Drugs in Dermatology, 2025. Written by Daniel Alcalá Pérez and 10 co-authors. Major MEDLINE topics: Skin Care, Cancer Survivors, Neoplasms, Antineoplastic Agents. Cited 2 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: Cancer-treatment-related cutaneous adverse events (cAEs) are common and may severely impact quality of life (QoL) and decrease treatment outcomes. The Latin American Cutaneous Oncology Management (LACOM) project provides clinical insights into cancer-treatment-related cAEs, offering tools for preventing and managing cAEs. METHODS: LACOM I focuses on integrating education, prophylactic measures, and skincare in cancer treatment to improve treatment adherence, outcomes, and patients' and survivors' QoL. RESULTS: The LACOM panel provides evidence and opinion-based best practice recommendations for oncology skincare programs to support all stakeholders in the Latin American healthcare setting (Argentina, Chili, Colombia, Ecuador, Panama, Peru, and Mexico) working with oncology patients throughout the entire continuum of care to achieve optimal outcomes, improving cancer patients and survivors' QoL. Oncology skincare programs comprise hygiene, moisturization, and sun protection with products that should be safe and help to minimize cAEs and improve skin conditions. CONCLUSIONS: Integrating education, general measures, and skincare programs into cancer treatment should encourage the adoption of a proactive role of skincare from the beginning of treatment and ongoing, supporting optimal outcomes and improving cancer patients' and survivors' QoL. J Drugs Dermatol. 2025;24(3):262-268. doi:10.36849/JDD.8565.

Subjects

MeSH terms (MEDLINE)

Skin CareCancer SurvivorsNeoplasmsAntineoplastic AgentsSkin DiseasesHumansQuality of LifeLatin AmericaPatient Education as TopicPractice Guidelines as Topic

Substances

Antineoplastic Agents

Cite

APA

Pérez, D. A., Acosta Madiedo, A. S., Andreani, S., Andriessen, A., Cárdenas, H., Moreno, M., Motola Kuba, D., Riganti, J., Enrique Ollague, J., Lacouture, M., & Toquica, A. (2025). Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8565

Vancouver

Pérez DA, Acosta Madiedo AS, Andreani S, Andriessen A, Cárdenas H, Moreno M, et al. Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8565

BibTeX
@article{Prez2025,
  author = {Pérez, Daniel Alcalá and Acosta Madiedo, Ana Sofia and Andreani, Sebastian and Andriessen, Anneke and Cárdenas, Hebert and Moreno, Marcela and Motola Kuba, Daniel and Riganti, Julia and Enrique Ollague, José and Lacouture, Mario and Toquica, Alejandra},
  title = {Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.8565}
}
Start for free →